The provisional codes will become effective if and when the FDA grants emergency use authorization or full approval to Pfizer’s COVID-19 vaccine in children ages 5 to 11.
The AMA said it published the code now to ensure providers are prepared in advance of the FDA decision.
“The AMA supports the goal of extending COVID-19 immunization protection to a broader age range of children,” said AMA President Gerald Harmon, MD.
The AMA added the following codes:
- 91307, the Pfizer vaccine product code for pediatric patients
- 0071A, the vaccine administration code for the first dose for pediatric patients
- 0072A, the vaccine administration code for the second dose for pediatric patients
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
